Genetic susceptibility to coronary artery disease: from promise to progress (original) (raw)

• Mackay, J. & Mensah, G. (eds) The Atlas of Heart Disease and Stroke (WHO, Geneva, Switzerland, 2004).
  Google Scholar
• Lusis, A. J., Mar, R. & Pajukanta, P. Genetics of atherosclerosis. Annu. Rev. Genomics Hum. Genet. 5, 189–218 (2004).
  Article CAS PubMed Google Scholar
• Libby, P. Inflammation in atherosclerosis. Nature 420, 868–874 (2002).
  Article CAS PubMed Google Scholar
• Zdravkovic, S. et al. Heritability of death from coronary heart disease: a 36-year follow-up of 20,966 Swedish twins. J. Intern. Med. 252, 247–254 (2002).
  Article CAS PubMed Google Scholar
• Wright, A., Charlesworth, B., Rudan, I., Carothers, A. & Campbell, H. A polygenic basis for late-onset disease. Trends Genet. 19, 97–106 (2003).
  Article CAS PubMed Google Scholar
• Myers, R. H., Kiely, D. K., Cupples, L. A. & Kannel, W. B. Parental history is an independent risk factor for coronary artery disease:the Framingham study. Am. Heart J. 120, 963–969 (1990).
  Article CAS PubMed Google Scholar
• Wilson, P. W. et al. Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837–1847 (1998).
  Article CAS PubMed Google Scholar
• Lloyd-Jones, D. M. et al. Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring. JAMA 291, 2204–2211 (2004).
  Article CAS PubMed Google Scholar
• Assmann, G., Cullen, P. & Schulte, H. Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Munster (PROCAM) study. Circulation 105, 310–315 (2002).
  Article PubMed Google Scholar
• Yusuf, S. et al. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case–control study. Lancet 364, 937–952 (2004).
  Article PubMed Google Scholar
• Weiss, K. M. & Terwilliger, J. D. How many diseases does it take to map a gene with SNPs? Nature Genet. 26, 151–157 (2000).
  Article CAS PubMed Google Scholar
• Cohen, J. C. et al. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science 305, 869–872 (2004).
  Article CAS PubMed Google Scholar
• Rudan, I. et al. Inbreeding and risk of late onset complex disease. J. Med. Genet. 40, 925–932 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Lohmueller, K. E., Pearce, C. L., Pike, M., Lander, E. S. & Hirschhorn, J. N. Meta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common disease. Nature Genet. 33, 177–182 (2003).
  Article CAS PubMed Google Scholar
• Wang, L., Fan, C., Topol, S. E., Topol, E. J. & Wang, Q. Mutation of MEF2A in an inherited disorder with features of coronary artery disease. Science 302, 1578–1581 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Bhagavatula, M. R. et al. Transcription factor MEF2A mutations in patients with coronary artery disease. Hum. Mol. Genet. 13, 3181–3188 (2004).
  Article CAS PubMed Google Scholar
• Gonzalez, P. et al. The Pro279Leu variant in the transcription factor MEF2A is associated with myocardial infarction. J. Med. Genet. 15 Jun 2005 [epub ahead of print].
• Weng, L. et al. Lack of MEF2A mutations in coronary artery disease. J. Clin. Invest. 115, 1016–1020 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Helgadottir, A. et al. The gene encoding 5-lipoxygenase activating protein confers risk of myocardial infarction and stroke. Nature Genet. 36, 233–239 (2004). A landmark positional cloning study, as it was the first to use linkage, linkage-disequilibrium mapping and functional studies to identify a CAD-susceptibility gene.
  Article CAS PubMed Google Scholar
• Spanbroek, R. et al. Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesis. Proc. Natl Acad. Sci. USA 100, 1238–1243 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• Mehrabian, M. et al. Identification of 5-lipoxygenase as a major gene contributing to atherosclerosis susceptibility in mice. Circ. Res. 91, 120–126 (2002).
  Article CAS PubMed Google Scholar
• Aiello, R. J. et al. Leukotriene B4 receptor antagonism reduces monocytic foam cells in mice. Arterioscler. Thromb. Vasc. Biol. 22, 443–449 (2001).
  Article CAS Google Scholar
• Dwyer, J. H. et al. Arachidonate 5-lipoxygenase promoter genotype, dietary arachidonic acid, and atherosclerosis. N. Engl. J. Med. 350, 29–37 (2004).
  Article CAS PubMed Google Scholar
• Danesh, J. et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N. Engl. J. Med. 350, 1387–1397 (2004).
  Article CAS PubMed Google Scholar
• Paul, A. et al. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation 109, 647–655 (2004).
  Article CAS PubMed Google Scholar
• Fletcher, L. Genomics companies shop around for chemical expertise. Nature Biotechnol. 22, 137–138 (2004).
  Article CAS Google Scholar
• Broeckel, U. et al. A comprehensive linkage analysis for myocardial infarction and its related risk factors. Nature Genet. 30, 210–214 (2002).
  Article CAS PubMed Google Scholar
• Wang, Q et al. Premature myocardial infarction novel susceptibility locus on chromosome 1P34–36 identified by genomewide linkage analysis. Am. J. Hum. Genet. 74, 262–271 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Hauser, E. R. et al. A genomewide scan for early-onset coronary artery disease in 438 families: the GENECARD Study. Am. J. Hum. Genet. 75, 436–447 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Harrap, S. B. et al. Genome-wide linkage analysis of the acute coronary syndrome suggests a locus on chromosome 2. Arterioscler. Thromb. Vasc. Biol. 22, 874–878 (2002).
  Article CAS PubMed Google Scholar
• Chiodini, B. D. & Lewis, C. M. Meta-analysis of 4 coronary heart disease genome-wide linkage studies confirms a susceptibility locus on chromosome 3q. Arterioscler. Thromb. Vasc. Biol. 23, 1863–1868 (2003).
  Article CAS PubMed Google Scholar
• Campbell, L. A. & Kuo, C. C. Chlamydia pneumoniae — an infectious risk factor for atherosclerosis? Nature Rev. Microbiol. 2, 23–32 (2004).
  Article CAS Google Scholar
• LeVan, T. D. et al. A common single nucleotide polymorphism in the CD14 promoter decreases the affinity of Sp protein binding and enhances transcriptional activity. J. Immunol. 167, 5838–5844 (2001).
  Article CAS PubMed Google Scholar
• Arroyo-Espliguero, R., Avanzas, P., Jeffery, S. & Kaski, J. C. CD14 and toll-like receptor 4: a link between infection and acute coronary events? Heart 90, 983–988 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Pasterkamp, G. J., van Keulen, K. & de Kleijn, D. P. V. Role of Toll-like receptor 4 in the initiation and progression of atherosclerotic disease. Eur. J. Clin. Invest. 34, 328–334 (2004).
  Article CAS PubMed Google Scholar
• Kiechl, S. et al. Toll-like receptor 4 polymorphisms and atherogenesis. N. Engl. J. Med. 47, 185–192 (2002).
  Article Google Scholar
• Ameziane, N. et al. Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events. Arterioscler. Thromb. Vasc. Biol. 23, e61–e64 (2003).
  Article PubMed CAS Google Scholar
• Boekholdt, S. M. et al. Variants of toll-like receptor 4 modify the efficacy of statin therapy and the risk of cardiovascular events. Circulation 107, 2416–2132 (2003).
  Article CAS PubMed Google Scholar
• Michelsen, K. S. et al. Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E. Proc. Natl Acad. Sci. USA. 101, 10679–10684 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Edfeldt, K. et al. Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction. Eur. Heart J. 25, 1447–1453 (2004).
  Article CAS PubMed Google Scholar
• Yang, I. A., Holloway, J. W. & Ye, S. TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis. Atherosclerosis 170, 187–190 (2003).
  Article CAS PubMed Google Scholar
• Colhoun, H. M., McKeigue, P. M. & Davey Smith, G. Problems of reporting genetic associations with complex outcomes. Lancet 361, 865–872 (2003).
  Article PubMed Google Scholar
• Keavney, B. et al. Large-scale test of hypothesised associations between the angiotensin-converting-enzyme insertion/deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 355, 434–442 (2000).
  Article CAS PubMed Google Scholar
• Hirschhorn, J. N. & Daly, M. J. Genome-wide association studies for common diseases and complex traits. Nature Rev. Genet. 6, 95–108 (2005).
  Article CAS PubMed Google Scholar
• Farrall, M. & Morris, A. P. Gearing up for genome-wide gene-association studies. Hum. Mol. Genet. 14 (Suppl. 2), R157–R162 (2005).
  Article CAS PubMed Google Scholar
• Risch, N. & Merikangas, K. The future of genetic studies of complex human diseases. Science 273, 1516–1517 (1996).
  Article CAS PubMed Google Scholar
• Ozaki, K. et al. Functional SNPs in the lymphotoxin-α gene that are associated with susceptibility to myocardial infarction. Nature Genet. 32, 650–654 (2002). A pioneering genome-scale gene-association study for susceptibility to myocardial infarction that identified causal variants in the LTA gene.
  Article CAS PubMed Google Scholar
• Iwanaga, Y. et al. Association analysis between polymorphisms of the lymphotoxin-α gene and myocardial infarction in a Japanese population. Atherosclerosis 172, 197–198 (2004).
  Article CAS PubMed Google Scholar
• Yamada, A. et al. Lack of association of polymorphisms of the lymphotoxin α gene with myocardial infarction in Japanese. J. Mol. Med. 82, 477–483 (2004).
  CAS PubMed Google Scholar
• The PROCARDIS Consortium. A trio family study showing association of the lymphotoxin-α N26 (804A) allele with coronary artery disease. Eur. J. Hum. Genet. 12, 770–774 (2004).
• Knight, J. C., Keating, B. J., Rockett, K. A. & Kwiatkowski, D. P. In vivo characterization of regulatory polymorphisms by allele-specific quantification of RNA polymerase loading. Nature Genet. 33, 469–475 (2003).
  Article CAS PubMed Google Scholar
• Knight, J. C., Keating, B. J. & Kwiatkowski, D. P. Allele-specific repression of lymphotoxin-α by activated B cell factor-1. Nature Genet. 36, 394–399 (2004).
  Article CAS PubMed Google Scholar
• Schreyer, S. A., Vick, C. M. & LeBoeuf, R. C. Loss of lymphotoxin-α but not tumor necrosis factor-α reduces atherosclerosis in mice. J. Biol. Chem. 277, 12364–12368 (2002).
  Article CAS PubMed Google Scholar
• Ozaki, K. et al. Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro. Nature 429, 72–75 (2004).
  Article CAS PubMed Google Scholar
• Cullen, P. et al. Rupture of the atherosclerotic plaque: does a good animal model exist? Arterioscler. Thromb. Vasc. Biol. 23, 535–542 (2003).
  Article CAS PubMed Google Scholar
• Wang, X. et al. Positional identification of TNFSF4, encoding OX40 ligand, as a gene that influences atherosclerosis susceptibility. Nature Genet. 37, 365–372 (2005).
  Article CAS PubMed Google Scholar
• Austin, M. A., Hokanson, J. E. & Edwards, K. L. Hypertriglyceridemia as a cardiovascular risk factor. Am. J. Cardiol. 81, 7B–12B (1998).
  Article CAS PubMed Google Scholar
• Rees, A., Shoulders, C. C., Stocks, J., Galton, D. J. & Baralle, F. E. DNA polymorphism adjacent to the human apolipoprotein A1 gene: relationship to hypertriglyceridemia. Lancet 1, 444–446 (1983).
  Article CAS PubMed Google Scholar
• van Dijk, K. W., Rensen, P. C., Voshol, P. J. & Havekes, L. M. The role and mode of action of apolipoproteins CIII and AV: synergistic actors in triglyceride metabolism? Curr. Opin. Lipidol. 15, 239–246 (2004).
  Article CAS PubMed Google Scholar
• Pennacchio, L. A. et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294, 169–173 (2001). An exemplary comparative genomics study that identified and characterized a novel apolipoprotein which was later implicated in human dyslipidaemia.
  Article CAS PubMed Google Scholar
• Shoulders, C. C., Jones, E. L. & Naoumova, R. P. Genetics of familial combined hyperlipidemia and risk of coronary heart disease. Hum. Mol. Genet. 13, R149–R160 (2004).
  Article CAS PubMed Google Scholar
• Goldstein, J. L., Schrott, H. G., Hazzard, W. R., Bierman, E. L. & Motulsky, A. G. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J. Clin. Invest. 52, 1544–1568 (1973).
  Article CAS PubMed PubMed Central Google Scholar
• Austin, M. A. et al. Cardiovascular disease mortality in familial forms of hypertriglyceridemia: A 20-year prospective study. Circulation 101, 2777–2782 (2000).
  Article CAS PubMed Google Scholar
• Wojciechowski, A. P. et al. Familial combined hyperlipidaemia linked to the apolipoprotein AI-CII-AIV gene cluster on chromosome 11q23–q24. Nature 349, 161–164 (1991).
  Article CAS PubMed Google Scholar
• Castellani, L. W. et al. Mapping a gene for combined hyperlipidaemia in a mutant mouse strain. Nature Genet. 18, 374–377 (1998).
  Article CAS PubMed Google Scholar
• Bodnar, J. S. et al. Positional cloning of the combined hyperlipidemia gene Hyplip1. Nature Genet. 30, 110–116 (2002).
  Article CAS PubMed Google Scholar
• Pajukanta, P. et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nature Genet. 36, 371–376 (2004). Following up on earlier linkage to chromosome 1q, gene-association studies excluded a candidate gene ( TXNIP ) that was implicated in mouse studies and instead identified a novel susceptibility gene that has a conserved intronic regulatory element.
  Article CAS PubMed Google Scholar
• Coon, H. et al. TXNIP gene not associated with familial combined hyperlipidemia in the NHLBI Family Heart Study. Atherosclerosis. 174, 357–362 (2004).
  Article CAS PubMed Google Scholar
• Putt, W. et al. Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum. Mol. Genet. 13, 1587–1597 (2004).
  Article CAS PubMed Google Scholar
• Naukkarinen, J. et al. USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum. Mol. Genet. 14, 2595–2605 (2005).
  Article CAS PubMed Google Scholar
• Farrall, M. Quantitative genetic variation: a post-modern view. Hum. Mol. Genet. 13, R1–R7 (2004).
  Article CAS PubMed Google Scholar
• Morley, M. et al. Genetic analysis of genome-wide variation in human gene expression. Nature 430, 743–747 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Swanberg, M. et al. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Nature Genet. 37, 486–494 (2005).
  Article CAS PubMed Google Scholar
• Marchini, J., Cardon, L. R., Phillips, M. S. & Donnelly, P. The effects of human population structure on large genetic association studies. Nature Genet. 36, 512–517 (2004).
  Article CAS PubMed Google Scholar
• Keavney, B. Commentary: Katan's remarkable foresight: genes and causality 18 years on. Int. J. Epidemiol. 33, 11–14 (2004).
  Article PubMed Google Scholar
• Benjamin, E. J. et al. Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Heart Study. Circulation 109, 613–619 (2004).
  Article PubMed Google Scholar
• Mitchell, G. F. et al. Heritability and a genome-wide linkage scan for arterial stiffness, wave reflection, and mean arterial pressure: the Framingham Heart Study. Circulation 112, 194–199 (2005).
  Article PubMed Google Scholar
• Jansen, R. C. & Nap, J. P. Genetical genomics: the added value from segregation. Trends Genet. 17, 388–391 (2001).
  Article CAS PubMed Google Scholar
• Schadt, E. E. et al. An integrative genomics approach to infer causal associations between gene expression and disease. Nature Genet. 37, 710–717 (2005).
  Article CAS PubMed Google Scholar
• Jansen, R. C. & Nap, J. P. Regulating gene expression: surprises still in store. Trends Genet. 20, 223–225 (2004).
  Article CAS PubMed Google Scholar
• Cervino, A.C. et al. Integrating QTL and high-density SNP analyses in mice to identify Insig2 as a susceptibility gene for plasma cholesterol levels. Genomics. 86, 505–517 (2005).
  Article CAS PubMed Google Scholar
• Mehrabian, M. et al. Integrating genotypic and expression data in a segregating mouse population to identify 5-lipoxygenase as a susceptibility gene for obesity and bone traits. Nature Genet. 37, 1224–1233 (2005).
  Article CAS PubMed Google Scholar
• Helgadottir, A. et al. A variant of the gene encoding leukotriene A4 hydrolase confers ethnicity-specific risk of myocardial infarction. Nature Genet. 38, 68–74 (2006).
  Article CAS PubMed Google Scholar
• Choudhury, R. P. Fuster, V. & Fayad, Z. A. Molecular, cellular and functional imaging of atherothrombosis. Nature Rev. Drug Discov. 3, 913–925 (2004).
  Article CAS Google Scholar